Drug discovery and Development

The primary objective of toxicology studies in the drug development process is to evaluate the safety of potential drug candidates. This is accomplished using relevant animal models and validated procedures. The ultimate goal is to translate the animal model responses into an understanding of the risk for human subjects. To this end, the toxicologist must be aware of the international guidelines for safety evaluation, as well as traditional and non-traditional toxicology models.

  • Pre-clinical trials |Animal methods
  • Clinical Trials
  • In vitro-studies
  • In vivo studies
  • Pharmacovigilance

Related Conference of Drug discovery and Development

March 09-10, 2022

23rd European Toxicology and Applied Pharmacology

Barcelona, Spain
June 02-03, 2022

ENVIRONMENTAL TOXICOLOGY AND HEALTH

Manila, Philippines
September 05-06, 2022

World Congress on Toxicology and Applied Pharmacology

Paris, France

Drug discovery and Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in